Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Other Non-Current Assets (2017 - 2020)

Historic Other Non-Current Assets for Sunshine Biopharma (SBFMW) over the last 4 years, with Q4 2020 value amounting to $7590.0.

  • Sunshine Biopharma's Other Non-Current Assets changed 0.0% to $7590.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $7590.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $7590.0 for FY2020, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2020, Sunshine Biopharma's Other Non-Current Assets is $7590.0, which was down 0.0% from $7590.0 recorded in Q4 2019.
  • Sunshine Biopharma's 5-year Other Non-Current Assets high stood at $989572.0 for Q4 2018, and its period low was $7590.0 during Q4 2019.
  • Moreover, its 4-year median value for Other Non-Current Assets was $43940.0 (2017), whereas its average is $271260.5.
  • Per our database at Business Quant, Sunshine Biopharma's Other Non-Current Assets surged by 113249.72% in 2018 and then plummeted by 9923.3% in 2019.
  • Over the past 4 years, Sunshine Biopharma's Other Non-Current Assets (Quarter) stood at $80290.0 in 2017, then surged by 1132.5% to $989572.0 in 2018, then plummeted by 99.23% to $7590.0 in 2019, then changed by 0.0% to $7590.0 in 2020.
  • Its Other Non-Current Assets stands at $7590.0 for Q4 2020, versus $7590.0 for Q4 2019 and $989572.0 for Q4 2018.